NCT03152591View on ClinicalTrials.gov

Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

July 24, 2017

Primary Completion Date

June 25, 2018

Study Completion Date

June 25, 2018

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

LIK066

LIK066 tablets for oral administration

DRUG

Placebo

Placebo tablets matching LIK066 tablets, for oral administration

Trial Locations (5)

10117

Novartis Investigative Site, Berlin

19104

Novartis Investigative Site, Philadelphia

45147

Novartis Investigative Site, Essen

65802

Novartis Investigative Site, Springfield

79106

Novartis Investigative Site, Freiburg im Breisgau

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY